191 episodes

Primary Care Today features conversations with clinical experts representing a wide range of medical specialties to highlight the latest trends in primary care practice, from clinical pearls to updated guidelines, health informatics, and practice management. This series is hosted by Dr. Brian McDonough, a nationally recognized clinical expert, teacher, and public speaker in primary care.

Primary Care Today ReachMD

    • Science
    • 3.4 • 20 Ratings

Primary Care Today features conversations with clinical experts representing a wide range of medical specialties to highlight the latest trends in primary care practice, from clinical pearls to updated guidelines, health informatics, and practice management. This series is hosted by Dr. Brian McDonough, a nationally recognized clinical expert, teacher, and public speaker in primary care.

    Part 1: Are You Ready for Biosimilars? What the Oncology Team Should Know

    Part 1: Are You Ready for Biosimilars? What the Oncology Team Should Know

    Host: Matt Birnholz, MD

    Guest: Gary Cohen, MD


    What’s the difference between a generic drug and biosimilar? How does the FDA define biosimilarity? And how are biosimilars developed? Get answers to these and other questions with Dr. Gary Cohen, Associate Professor of Oncology at John’s Hopkins School of Medicine and Emeritus Director of the Sandra and Malcolm Berman Cancer Institute at GBMC, in the first episode of this two-part video.
    ©2020 Amgen Inc. All rights reserved. USA-CBU-80726 10/20

    Part 2: Are You Ready for Biosimilars? What the Oncology Team Should Know

    Part 2: Are You Ready for Biosimilars? What the Oncology Team Should Know

    Host: Matt Birnholz, MD

    Guest: Gary Cohen, MD


    Biosimilars undergo a rigorous evaluation process to ensure high quality and no clinically meaningful difference between biosimilars and the reference product. To learn more about how biosimilar clinical trials are designed to confirm biosimilarity, tune in to the second episode of this two-part series featuring Dr. Gary Cohen, Associate Professor of Oncology at John’s Hopkins School of Medicine and Emeritus Director of the Sandra and Malcolm Berman Cancer Institute at GBMC.
    ©2020 Amgen Inc. All rights reserved. USA-CBU-80729 10/20

    Monoclonal Antibodies & Small Molecules: What Clinicians Need to Know

    Monoclonal Antibodies & Small Molecules: What Clinicians Need to Know

    Host: Jennifer Caudle, DO

    Guest: Peter McAllister, MD


    While both small molecule drugs and monoclonal antibodies are considered targeted therapies, they each have unique characteristics that may influence how they’re used to treat diseases. That’s why Dr. Peter McAllister is here to explain how these two modalities differ in terms of structure, administration routes, and distribution.
    USA-334-83595

    Vaccinations: How Can HCPs Respond to Patients Choosing Not to Get Them?

    Vaccinations: How Can HCPs Respond to Patients Choosing Not to Get Them?

    Guest: Jennifer Caudle, DO


    It’s an unfortunate reality that an increasing number of patients are refusing to get vaccinated—regardless of whether that’s the recommendation for themselves or their children. But luckily, there are ways you can talk to your patients about this, as Dr. Jennifer Caudle explains.

    Strategies for Success: Exercising Our Mental Muscle

    Strategies for Success: Exercising Our Mental Muscle

    Host: Brian P. McDonough, MD, FAAFP

    Guest: Kisma Orbovich


    Improvement is something we’re all constantly chasing, whether it’s in the form of a promotion, a bigger house, or maybe even an ideal weight. So why do we often fail miserably at these attempts to make our lives better?
    To get to the bottom of this dilemma, Dr. Brian McDonough is joined by Kisma Orbovich, the CEO of Illumination Academy, to reveal the secret to true success and how gratitude may just be the lifehack we’ve been searching for.

    How Artificial Intelligence Fits into the Pharmaceutical Industry

    How Artificial Intelligence Fits into the Pharmaceutical Industry

    Host: Brian P. McDonough, MD, FAAFP

    Guest: Cecilia Van Cauwenberghe


    What was once a sci-fi tale is now a reality, but unlike the aliens and monsters common to this genre, artificial intelligence isn’t something healthcare professionals need to fear. On the contrary, it may just be the key to unlocking new solutions in the pharmaceutical industry, as Dr. Cecilia Van Cauwenberghe explains.

Customer Reviews

3.4 out of 5
20 Ratings

20 Ratings

piancher ,

Chiropractor? Really?

I am a resident and was really enjoying your show. Stopped listening halfway through the episode with the chiropractor who was a "specialist" in emotions. He actually said unresolved emotions cause cancer. I lost all respect after that and as a scientist and a doctor won't be listening anymore. I thought your shoe was really well done till that point. Just wanted you to know that.

Top Podcasts In Science

Listeners Also Subscribed To